ETF Channels
ETF Strategist
Relative Value
Core ETF
Multi-Asset
Equity ETF
Smart Beta
Innovative ETFs
Tactical Allocation
Thematic Investing
Fixed Income
Alternatives
Leveraged & Inverse
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – PowerShares QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top 34 Gold ETFs
Top 34 Oil ETFs
Top 130 Commodity ETFs
Top 47 Hedge Fund ETFs
Top 57 Financials ETFs
Top 68 Inverse Equities ETFs
Top 56 High Yield Bond ETFs
ETF Topics
New ETFs
ETF Investing
Equity ETFs
Alternative ETFs
ETF Ecosystem
ETF Education
Education Central
Video
Podcasts
ETF Playbook
Free Sign Up
BIS
Featured
Getting it Right (and Wrong) With Leveraged Biotech ETFs
By
Todd Shriber
March 25, 2015
Featured
ProShares to Reverse Split 10 Inverse, Leveraged ETFs
By
Tom Lydon
October 15, 2014
Alternative ETFs
Most Searched ETFs: All Over the Map
By
Todd Shriber
September 6, 2014
Featured
After a Rally, Biotech ETF Faces Resistance
By
Todd Shriber
June 11, 2014
Alternative ETFs
Most Searched ETFs: Some Changes, but a few Surprises
By
Todd Shriber
April 12, 2014
Featured
Biotech Bumble: ETFs Fall to 2014 Lows
By
Todd Shriber
April 10, 2014
Featured
Investors Say Bye-Bye to Biotech ETFs
By
Todd Shriber
April 8, 2014
Equity ETFs
Most Searched ETFs: A Global Flare
By
Todd Shriber
April 5, 2014
Featured
Inverse Biotech Suddenly Cool Kid at ETF Party
By
Max Chen
April 4, 2014
Featured
Biotech ETFs Hold Their Breath
By
Max Chen
March 28, 2014
Featured
A Gutsy Technical Call on a Biotech ETF
By
Tom Lydon
March 27, 2014
Featured
Not Just Biotech: Other Momo ETFs Taken to Task
By
Tom Lydon
March 24, 2014
Featured
Overlooked Bearish Biotech ETF Grows Up…Sort Of
By
Todd Shriber
March 21, 2014
Featured
Dissipate the Risk In Biotechnology With ETFs
By
Tom Lydon
January 18, 2011
Featured
New ETFs: Single-Country Small-Caps and Leveraged Biotech
By
Tom Lydon
April 15, 2010
Previous
1
2
X